Medications for opioid use disorder are associated with reduced risk of repeat opioid overdose in Medicaid: A cohort study
The objective of this study was to examine the association of MOUD after nonfatal opioid overdose with risk of repeat overdose in the following year. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 18, 2023 Category: Addiction Authors: Andrew D. Tipping, Molly Nowels, Clara Moore, Hillary Samples, Stephen Crystal, Mark Olfson, Arthur Robinson Williams, Jodi Heaps-Woodruff Source Type: research

Activity space during treatment with medication for opioid use disorder: Relationships with personality, mood, and drug use
Activity space in people with substance use disorders (SUDs) has been assessed for theoretical reasons and for detection/prevention of relapse. In this observational study, we relate passively obtained activity space measures to mental states and behaviors relevant to the success of treatment for opioid use disorder. Our long-term goal is to use such data to assess risk in real time and to recognize when SUD patients might benefit from a just-in-time intervention. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 17, 2023 Category: Addiction Authors: Leigh V. Panlilio, Albert J. Burgess-Hull, Jeffrey D. Feldman, Jeffrey M. Rogers, Matthew Tyburski, Kirsten E. Smith, David H. Epstein Source Type: research

Linkage facilitation services for opioid use disorder: Taxonomy of facilitation practitioners, goals, and activities
This article proposes a taxonomy of linkage facilitation services used to help persons with opioid use disorder access treatment and recovery resources. Linkage facilitation may be especially valuable for persons receiving medication for opioid use disorder (MOUD) given the considerable barriers to treatment access and initiation that have been identified. The science of linkage facilitation currently lacks both consistent communication about linkage facilitation practices and a conceptual framework for guiding research. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 17, 2023 Category: Addiction Authors: Aaron Hogue, Milan F. Satcher, Tess K. Drazdowski, Angela Hagaman, Patrick F. Hibbard, Ashli J. Sheidow, Anthony Coetzer-Liversagef, Shannon Gwin Mitchell, Dennis P. Watson, Khirsten J. Wilson, Frederick Muench, Marc Fishman, Kevin Wenzel, Sierra Castedo Source Type: research

Changes in buprenorphine waivered provider supply after Virginia Medicaid implements the addiction and recovery treatment services program and Medicaid expansion
Shortages of providers authorized to prescribe buprenorphine may limit access to buprenorphine, which studies have shown to be effective in the treatment of opioid use disorder (OUD). (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 16, 2023 Category: Addiction Authors: Atika Farzana Urmi, Erin Britton, Heather Saunders, Ashley Harrell, Chethan Bachireddy, Jason Lowe, Andrew J. Barnes, Peter Cunningham Source Type: research

Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets
This study explores barriers to treatment access among individuals with opioid use disorder (OUD) experiencing homelessness. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 16, 2023 Category: Addiction Authors: Michael Hsu, Olivia S. Jung, Li Ting Kwan, Oluwole Jegede, Bianca Martin, Aniket Malhotra, Joji Suzuki Source Type: research

Association of current substance use treatment with future reduced methamphetamine use in an observational cohort of men who have sex with men in Los Angeles
This study aimed to describe trajectories of methamphetamine use among MSM, and to evaluate the impact of treatment for any kind of substance use on frequency of methamphetamine use. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 16, 2023 Category: Addiction Authors: Allison D. Rosen, Marjan Javanbakht, Steven J. Shoptaw, Marissa J. Seamans, James O. Lloyd-Smith, Pamina M. Gorbach Source Type: research

Perspectives on APRN prescribing of medications for opioid use disorder: Key barriers remain
Deaths from drug overdoses are rising dramatically in the United States. Treatment for opioid use disorders may include behavioral treatments as well as medications for opioid use disorders (MOUD). Buprenorphine can be prescribed by physicians, nurse practitioners (NPs), other advanced practice registered nurses (APRNs), and physician assistants (PAs) and required a training and a federal waiver until recently. The number of NP MOUD prescribers grew steadily over the past decade, but research has identified state-level scope of practice regulations as a barrier to NP MOUD prescribing. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 16, 2023 Category: Addiction Authors: Susan A. Chapman, Leah Fraimow-Wong, Bethany J. Phoenix, Matthew Tierney, Joanne Spetz Source Type: research

A computer-assisted telephone collaborative care intervention provided by lay providers for the treatment of comorbid depression and at-risk drinking: Analysis of a randomized controlled trial
Virtual collaborative care for people with comorbid depression and at-risk drinking lacks strong evidence. Our aim was to assess the impact of 12  months of telephone collaborative care (tCC) versus enhanced usual care (eUC) on depression and drinking. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 6, 2023 Category: Addiction Authors: Helena K. Kim, Osnat C. Melamed, Matthew Sloan, M. Ishrat Husain, David J. Rodie, Athina Perivolaris, Paul Kurdyak, David W. Oslin, Rose Geist, Peter Selby, Benoit H. Mulsant, the PARTNERs Study Group Source Type: research

Increasing access to quality care for pregnant and postpartum people with opioid use disorder: Coordination of services, provider awareness and training, extended postpartum coverage, and perinatal quality collaboratives
Fifteen states participating in the Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community (OMNI LC) developed action plan goals and activities to address the rise in opioid use disorder (OUD) among birthing persons. In a separate initiative, Perinatal Quality Collaboratives (PQCs) from 12 states participating in Centers for Disease Control and Prevention (CDC)-supported activities hosted trainings to improve the provision of OUD services and implement protocols for screening and treatment in delivery facilities. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 5, 2023 Category: Addiction Authors: Kecia L. Ellick, Charlan D. Kroelinger, Karen Chang, Molly McGown, Matthew McReynolds, Alisa J. Velonis, Emily Bronson, Tiffany Riehle-Colarusso, Ellen Pliska, Sanaa Akbarali, Trish Mueller, Ramya Dronamraju, Shanna Cox, Wanda D. Barfield Source Type: research

Evaluation of opioid use disorder treatment outcomes in patients receiving split daily versus once daily dosing of buprenorphine-naloxone
This study aims to evaluate how the dosing frequency of SL buprenorphine-naloxone impacts therapy effectiveness when treating patients with OUD. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 5, 2023 Category: Addiction Authors: Joshua B. Borris, Caitlin Dowd-Green, Lindsay A. Bowman, Suzanne A. Nesbit, Michael Fingerhood, Rosalyn W. Stewart Source Type: research

Dreaming death: Living with loss in the U.S. overdose crisis
Enter the dining room at Sunrise,1 a residential drug treatment program in Northeast Ohio, and one is struck by a 3  × 2–foot bulletin board filled with resident art, Alcoholics Anonymous (AA) announcements, and, increasingly, obituaries. Residents stare at the obituaries in the stark quiet of the hall, deserted between meetings. The smiling faces of former residents return their gaze, evoking recognition, and the sting of loss. They hang like ghosts: reminders of the precarity of life and the proximity of death to those who enter and leave Sunrise. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 5, 2023 Category: Addiction Authors: Allison V. Schlosser Source Type: research

Implementation of an office-based addiction treatment model for Medicaid enrollees: A mixed methods study
Medications for opioid use disorder (MOUD) are the most effective treatment for opioid use disorder (OUD) but remain underutilized. To reduce barriers to MOUD prescribing and increase treatment access, New Jersey's Medicaid program implemented the Office-Based Addiction Treatment (OBAT) Program in 2019, which increased reimbursement for office-based buprenorphine prescribing and established newly reimbursable patient navigation services in OBAT clinics. Using a mixed-methods design, this study aimed to describe stakeholder experiences with the OBAT program and to assess implementation and uptake of the program. (Source: Jo...
Source: Journal of Substance Abuse Treatment - November 5, 2023 Category: Addiction Authors: Peter Treitler, Michael Enich, Cadence Bowden, Anais Mahone, James Lloyd, Stephen Crystal Source Type: research

Clinical characteristics and prognostic factors among hospitalized patients with substance use disorders: Findings from a retrospective cohort study of a Canadian inpatient addiction medicine service
Inpatient addiction medicine services (AMS) were developed in response to the growing needs of hospitalized individuals with substance use disorders (SUDs). AMS aim to enable timely initiation of pharmacologic treatment, build hospital capacity to support patients who use substances, and facilitate transition to community services. As an emerging service being adopted in hospitals across North America, the model of care, populations served, substance use trends, and clinical trajectory has not been widely described. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 4, 2023 Category: Addiction Authors: Leslie J. Martin, Monica Bawor, Supriya Bains, Jacinda Burns, Saba Khoshroo, Myra Massey, Jane DeJesus, Robin Lennox, Lauren Cook-Chaimowitz, Tim O'Shea, James MacKillop, Brittany B. Dennis Source Type: research

Anxiety sensitivity reduction-smoking cessation intervention among individuals who engage in dual cigarette and cannabis use: A secondary analysis
Cannabis use among individuals who smoke is prevalent in the general population and related to adverse health effects, including higher levels of interoceptive perturbation (i.e., a disturbance in internal experiences). An important aspect of smoking cessation among individuals who co-use cannabis is to address behavioral associations between physiological sensations and habitual behaviors via integrated treatments focused on reducing reactivity to internal perturbations such as anxiety sensitivity (i.e., the belief that such symptoms produce personal harm). (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - November 4, 2023 Category: Addiction Authors: Michael J. Zvolensky, Jafar Bakhshaie, Brooke Y. Redmond, Lorra Garey, Marcel de Dios, Miguel Ángel Cano, Norman B. Schmidt Source Type: research

Disparities in access to opioid treatment programs and buprenorphine providers by race and ethnicity in the contiguous U.S.
The burden of drug overdose mortality varies by race and ethnicity, with American Indian/Alaska Native (AI/AN), Black, and White people experiencing the largest burden. We analyzed census block group data to evaluate differences in travel distance to opioid treatment programs (OTP) and buprenorphine providers by race and ethnicity. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - October 27, 2023 Category: Addiction Authors: Solmaz Amiri, Victoria Panwala, Ofer Amram Source Type: research